Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: The breast cancer health disparities study

International Journal of Cancer

Volumn 134, Issue 3, 2014, Pages 629-644

  Slattery, Martha L ^a   John, Esther M ^b,c   Torres Mejia, Gabriela ^d   Lundgreen, Abbie ^a   Lewinger, Juan Pablo ^e   Stern, Mariana C ^e   Hines, Lisa ^f   Baumgartner, Kathy B ^g   Giuliano, Anna R ^h   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF LOUISVILLE   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

antioxidants; breast cancer; diet; FLT1; Hispanic; KDR; NOS2A; survival; TEK; VEGFA

Indexed keywords

ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROGESTERONE RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DDIT4 GENE; DIETARY OXIDATIVE BALANCE; FEMALE; FLT1 GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIF1A GENE; HUMAN; KDR GENE; MAJOR CLINICAL STUDY; MPO GENE; NOS2A GENE; NUTRITIONAL PARAMETERS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TEK GENE; TUMOR VASCULARIZATION; VEGFA GENE;

EID: 84888005563     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28377     Document Type: Article

References (39)

1. Shibuya M,. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2011; 2: 1097-105.
2. Shibuya M,. Tyrosine kinase receptor Flt/VEGFR family: its characterization related to angiogenesis and cancer. Genes Cancer 2010; 1: 1119-23.
3. Waldner MJ, Wirtz S, Jefremow A, et al. VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. J Exp Med 2010; 207: 2855-68.
4. Yoo SA, Kwok SK, Kim WU,. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm 2008; 2008: 129873.
5. Prager GW, Poettler M,. Angiogenesis in cancer. Basic mechanisms and therapeutic advances. Hamostaseologie 2012; 32: 105-14.
6. Jones N, Dumont DJ,. Tek/Tie2 signaling: new and old partners. Cancer Metastasis Rev 2000; 19: 13-17.
7. Dales JP, Garcia S, Carpentier S, et al. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Br J Cancer 2004; 90: 1216-21.
8. Min Y, Ren X, Vaught DB, et al. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res 2010; 70: 2819-28.
9. Wink DA, Vodovotz Y, Laval J, et al. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19: 711-21.
10. Henze AT, Acker T,. Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 2010; 9: 2749-63.
11. Reuter S, Gupta SC, Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-16.
12. Horak P, Crawford AR, Vadysirisack DD, et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 4675-80.
13. Arslan S, Pinarbasi H, Silig Y,. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population. Mol Med Rep 2011; 4: 87-92.
14. Slattery ML, Lundgreen A, Welbourn B, et al. Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes. Mutat Res 2012; 734: 30-40.
15. Slattery ML, John EM, Torres-Mejia G, et al. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 2012; 33: 1512-21.
16. Slattery ML, Sweeney C, Edwards S, et al. Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 2007; 102: 85-101.
17. John EM, Horn-Ross PL, Koo J,. Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 2003; 12 (11 Part 1): 1143-52.
18. John EM, Phipps AI, Davis A, et al. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 2005; 14: 2905-13.
19. Falush D, Stephens M, Pritchard JK,. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003; 164: 1567-87.
20. Pritchard JK, Stephens M, Donnelly P,. Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945-59.
21. Nyholt DR,. A simple correction for multiple testing of single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J. Human Genetics 2004; 74: 765-9.
22. Li J, Ji L,. Adjusting multiple testing in multilocus analysis using the eigenvalues of a correlatioin matrix. Heredity 2005; 95: 221-7.
23. Yu K, Li Q, Bergen AW, et al. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; 33: 700-9.
24. Kai Yu, Li Q, Wheeler W., ARTP gene and pathway p-values computed using the adaptive rank truncated product, 2.0.0 edn., R package, 2011.
25. Jacobs EJ, Feigelson HS, Bain EB, et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006; 8: R22.
26. Schneider BP, Radovich M, Sledge GW, et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008; 111: 157-63.
27. Langsenlehner U, Wolf G, Langsenlehner T, et al. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study. Breast Cancer Res Treat 2008; 109: 297-304.
28. Jin Q, Hemminki K, Enquist K, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005; 11: 3647-53.
29. Oliveira C, Lourenco GJ, Silva PM, et al. Polymorphisms in the 5'- and 3'-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics. Tumour Biol 2011; 32: 295-300.
30. Balasubramanian SP, Cox A, Cross SS, et al. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007; 121: 1009-16.
31. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468-71.
32. Rodrigues P, Furriol J, Tormo E, et al. The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. Breast Cancer Res Treat 2012; 133: 769-78.
33. Kataoka N, Cai Q, Wen W, et al. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006; 15: 1148-52.
34. Beeghly-Fadiel A, Shu XO, Lu W, et al. Genetic variation in VEGF family genes and breast cancer risk: A report from the Shanghai Breast Cancer Genetics Study. CEBP 2011; 20: 33-44.
35. Wedam SB, Low JA, Yang SX, et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol 2006; 24: 769-77.
36. Rossant J, Howard L,. Signaling pathways in vascular development. Annu Rev Cell Dev Biol 2002; 18: 541-73.
37. Venneri MA, De Palma M, Ponzoni M, et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007; 109: 5276-85.
38. Porta C, Larghi P, Rimoldi M, et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009; 214: 761-77.
39. Martin V, Liu D, Fueyo J, et al. Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol 2008; 23: 773-80.